BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27430308)

  • 1. MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells.
    Deng W; Wang Y; Gu L; Duan B; Cui J; Zhang Y; Chen Y; Sun S; Dong J; Du J
    BMC Cancer; 2016 Jul; 16():489. PubMed ID: 27430308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway.
    Deng W; Wang Y; Zhao S; Zhang Y; Chen Y; Zhao X; Liu L; Sun S; Zhang L; Ye B; Du J
    J Cell Mol Med; 2018 Jun; 22(6):3108-3118. PubMed ID: 29524295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
    Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
    Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
    Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
    Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
    Huang L; Lin H; Chen Q; Yu L; Bai D
    BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MICAL-L1 is a tubular endosomal membrane hub that connects Rab35 and Arf6 with Rab8a.
    Rahajeng J; Giridharan SS; Cai B; Naslavsky N; Caplan S
    Traffic; 2012 Jan; 13(1):82-93. PubMed ID: 21951725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of F-actin controls the terminal steps of cytokinesis.
    Frémont S; Hammich H; Bai J; Wioland H; Klinkert K; Rocancourt M; Kikuti C; Stroebel D; Romet-Lemonne G; Pylypenko O; Houdusse A; Echard A
    Nat Commun; 2017 Feb; 8():14528. PubMed ID: 28230050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
    Gao W; Han J
    Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.
    Lian X; Jiao Y; Yang Y; Wang Z; Xuan Q; Liu H; Lu S; Wang Z; Liu Y; Li S; Yang Y; Guo L; Zhao L; Zhang Q
    Med Oncol; 2015 Jan; 32(1):411. PubMed ID: 25476480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yin Y; Sui C; Meng F; Ma P; Jiang Y
    Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.
    Qiu YS; Jiang NN; Zhou Y; Yu KY; Gong HY; Liao GJ
    Int J Mol Med; 2018 May; 41(5):2755-2763. PubMed ID: 29436606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
    Zhang Y; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):15389-15396. PubMed ID: 31026088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer.
    Hu J; Zhang L; Chen Q; Lin J; Wang S; Liu R; Zhang W; Miao K; Shou T
    Cell Biol Int; 2018 Nov; 42(11):1484-1491. PubMed ID: 29286212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Kim YJ; Hwang HJ; Kang JG; Kim CS; Ihm SH; Choi MG; Lee SJ
    Anticancer Res; 2018 Jun; 38(6):3515-3525. PubMed ID: 29848705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
    Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
    Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.